These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Biochemical effects of supplemented long-chain polyunsaturated fatty acids in hyperphenylalaninemia. Agostoni C; Scaglioni S; Bonvissuto M; Bruzzese MG; Giovannini M; Riva E Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):111-5. PubMed ID: 11237478 [TBL] [Abstract][Full Text] [Related]
6. Long-chain polyunsaturated fatty acid status in phenylketonuric patients treated with tetrahydrobiopterin. Vilaseca MA; Lambruschini N; Gómez-López L; Gutiérrez A; Moreno J; Tondo M; Artuch R; Campistol J Clin Biochem; 2010 Mar; 43(4-5):411-5. PubMed ID: 19948162 [TBL] [Abstract][Full Text] [Related]
7. Long-chain polyunsaturated fatty acid status in children, adolescents and adults with phenylketonuria. Gramer G; Haege G; Langhans CD; Schuhmann V; Burgard P; Hoffmann GF Prostaglandins Leukot Essent Fatty Acids; 2016 Jun; 109():52-7. PubMed ID: 27269713 [TBL] [Abstract][Full Text] [Related]
8. Supplementation with a powdered blend of PUFAs normalizes DHA and AA levels in patients with PKU. Jans JJ; de Sain-van der Velden MG; van Hasselt PM; van den Hurk DT; Vaz FM; Visser G; Verhoeven-Duif NM Mol Genet Metab; 2013 Jun; 109(2):121-4. PubMed ID: 23562298 [TBL] [Abstract][Full Text] [Related]
9. Dietary long-chain polyunsaturated fatty acid supplementation in infants with phenylketonuria: a randomized controlled trial. Koletzko B; Sauerwald T; Demmelmair H; Herzog M; von Schenck U; Böhles H; Wendel U; Seidel J J Inherit Metab Dis; 2007 Jun; 30(3):326-32. PubMed ID: 17431817 [TBL] [Abstract][Full Text] [Related]
10. Modification of milk formula to enhance accretion of long-chain n-6 and n-3 polyunsaturated fatty acids in artificially reared infant rats. Yeh YY; Yeh SM; Lien EL Lipids; 1998 May; 33(5):513-20. PubMed ID: 9625599 [TBL] [Abstract][Full Text] [Related]
11. A randomized trial of long-chain polyunsaturated fatty acid supplementation in infants with phenylketonuria. Agostoni C; Harvie A; McCulloch DL; Demellweek C; Cockburn F; Giovannini M; Murray G; Harkness RA; Riva E Dev Med Child Neurol; 2006 Mar; 48(3):207-12. PubMed ID: 16483397 [TBL] [Abstract][Full Text] [Related]
12. Reduced plasma C-20 and C-22 polyunsaturated fatty acids in children with phenylketonuria during dietary intervention. Galli C; Agostoni C; Mosconi C; Riva E; Salari PC; Giovannini M J Pediatr; 1991 Oct; 119(4):562-7. PubMed ID: 1919887 [TBL] [Abstract][Full Text] [Related]
13. Association between prenatal and current exposure to selected LCPUFAs and school performance at age 7. van der Wurff IS; Bakker EC; Hornstra G; Kirschner PA; Gielen M; Godschalk RW; Kremers S; Zeegers MP; de Groot RH Prostaglandins Leukot Essent Fatty Acids; 2016 May; 108():22-9. PubMed ID: 27154361 [TBL] [Abstract][Full Text] [Related]
14. Metabolomic Markers of Essential Fatty Acids, Carnitine, and Cholesterol Metabolism in Adults and Adolescents with Phenylketonuria. Stroup BM; Nair N; Murali SG; Broniowska K; Rohr F; Levy HL; Ney DM J Nutr; 2018 Feb; 148(2):194-201. PubMed ID: 29490096 [TBL] [Abstract][Full Text] [Related]
15. Increased ω-3 polyunsaturated fatty acid/arachidonic acid ratios and upregulation of signaling mediator in individuals with autism spectrum disorders. Yui K; Imataka G; Kawasak Y; Yamada H Life Sci; 2016 Jan; 145():205-12. PubMed ID: 26724495 [TBL] [Abstract][Full Text] [Related]
16. Krill oil reduces plasma triacylglycerol level and improves related lipoprotein particle concentration, fatty acid composition and redox status in healthy young adults - a pilot study. Berge RK; Ramsvik MS; Bohov P; Svardal A; Nordrehaug JE; Rostrup E; Bruheim I; Bjørndal B Lipids Health Dis; 2015 Dec; 14():163. PubMed ID: 26666303 [TBL] [Abstract][Full Text] [Related]
17. Plasma cholesterol in adults with phenylketonuria. Williams RA; Hooper AJ; Bell DA; Mamotte CD; Burnett JR Pathology; 2015 Feb; 47(2):134-7. PubMed ID: 25551302 [TBL] [Abstract][Full Text] [Related]
18. [Neurological, neuropsychological, and ophthalmological evolution after one year of docosahexaenoic acid supplementation in phenylketonuric patients]. Gutiérrez-Mata AP; Vilaseca MA; Capdevila-Cirera A; Vidal-Oller M; Alonso-Colmenero I; Colomé R; López-Sala A; Lambruschini-Ferri N; Gutiérrez A; Gassió R; Artuch R; Campistol J Rev Neurol; 2012 Aug; 55(4):200-6. PubMed ID: 22829083 [TBL] [Abstract][Full Text] [Related]
19. Fatty acid profile in patients with phenylketonuria and its relationship with bone mineral density. Lage S; Bueno M; Andrade F; Prieto JA; Delgado C; Legarda M; Sanjurjo P; Aldámiz-Echevarría LJ J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S363-71. PubMed ID: 20830525 [TBL] [Abstract][Full Text] [Related]
20. Associations of birth weight with serum long chain polyunsaturated fatty acids in adolescents; the HELENA study. Labayen I; Moreno LA; Ruiz JR; Ortega FB; Sjostrom M; Huybrechts I; Gonzalez-Gross M; Spinneker A; De Henauw S; Manios Y; Molnar D; Leclercq C; Gottrand F; Atherosclerosis; 2011 Jul; 217(1):286-91. PubMed ID: 21550607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]